Very encouragedBelow text in italics was posted by carmyk1 on the V2 board. The answer to his question is Yes. So the third patient met the criteria and we only need 5 more. Moving to a registration trial would be an absolutely huge event for this company. I can't over emphasize the "huge". Its only one patient and we won't know about others for a while and I know we've been disappointed before but the market cap of the company is quite low and the level of interest is low so it looks to me like a good place to add for speculative accounts.
David Miller at BTM reported that the protocol also states that if
there is a response rate of 15% or better, ONC will be able to expand
the trial to registration status. So one question is whether SD for
six months counts as a response for this aspect of the protocol. If
so, then one more good outcome from the five remaining patients and we
are on track.